{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:30:02Z","timestamp":1793788202811,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014434","name":"Irving Medical Center, Columbia University","doi-asserted-by":"publisher","award":["UL1 RR024156"],"award-info":[{"award-number":["UL1 RR024156"]}],"id":[{"id":"10.13039\/100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RO1 DA023650"],"award-info":[{"award-number":["RO1 DA023650"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.drugalcdep.2021.108554","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T02:18:16Z","timestamp":1612837096000},"page":"108554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Modafinil reduces smoked cocaine self-administration in humans: effects vary as a function of cocaine \u2018priming\u2019 and cost"],"prefix":"10.1016","volume":"221","author":[{"given":"Margaret","family":"Haney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Denson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Foltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.drugalcdep.2021.108554_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.108554_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugalcdep.2004.06.007","article-title":"Utility of lead-in period in cocaine dependence pharmacotherapy trials","volume":"77","author":"Bisaga","year":"2005","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.108554_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.07.009","article-title":"A randomized placebo-controlled trial of gabapentin for cocaine dependence","volume":"81","author":"Bisaga","year":"2006","journal-title":"Drug Alcohol Depend."},{"issue":"1-2","key":"10.1016\/j.drugalcdep.2021.108554_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugalcdep.2010.04.006","article-title":"A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period","volume":"111","author":"Bisaga","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/add.15242","article-title":"Pharmacotherapeutic strategies for treating cocaine use disorder - what do we have to offer?","author":"Brandt","year":"2021","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.drugalcdep.2021.108554_bib0030","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.addbeh.2014.02.015","article-title":"Preliminary evidence for normalization of risk taking by modafinil in chronic cocaine users","volume":"39","author":"Canavan","year":"2014","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.108554_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","article-title":"Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study","volume":"70","author":"Dackis","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.108554_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.108554_bib0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"issue":"6","key":"10.1016\/j.drugalcdep.2021.108554_bib0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.15288\/jsad.2011.72.943","article-title":"Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans","volume":"72","author":"Dean","year":"2011","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.108554_bib0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00213-001-0944-7","article-title":"The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women","volume":"159","author":"Evans","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2016.08.009","article-title":"Modafinil decreases cocaine choice in human cocaine smokers only when the response requirement and the alternative reinforcer magnitude are large","volume":"150-151","author":"Foltin","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0065","series-title":"Guidance for Industry. Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products","author":"Food and Drug Administration Center for Drug Evaluation and Research, C.f.B.E.a.R","year":"2019"},{"issue":"5","key":"10.1016\/j.drugalcdep.2021.108554_bib0070","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/npp.2010.233","article-title":"Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals","volume":"36","author":"Ghahremani","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.108554_bib0075","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.addbeh.2012.04.006","article-title":"Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI","volume":"38","author":"Goudriaan","year":"2013","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.108554_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1369-1600.2008.00121.x","article-title":"Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls","volume":"14","author":"Haney","year":"2009","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.108554_bib0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.108554_bib0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s002130100725","article-title":"Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans","volume":"155","author":"Haney","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"issue":"8","key":"10.1016\/j.drugalcdep.2021.108554_bib0095","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/sj.npp.1300999","article-title":"Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers","volume":"31","author":"Haney","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.108554_bib0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-011-2231-6","article-title":"Aripiprazole maintenance increases smoked cocaine self-administration in humans","volume":"216","author":"Haney","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.108554_bib0105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.108554_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","article-title":"An evaluation of the abuse potential of modafinil using methylphenidate as a reference","volume":"14","author":"Jasinski","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.neuropharm.2012.06.064","article-title":"Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users","volume":"64","author":"Kalechstein","year":"2013","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.drugalcdep.2021.108554_bib0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1532","article-title":"The treatment of cocaine use disorder","volume":"5","author":"Kampman","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.108554_bib0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.108554_bib0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1369-1600.2012.00506.x","article-title":"Modafinil attenuates reinstatement of cocaine seeking: role for cystine-glutamate exchange and metabotropic glutamate receptors","volume":"19","author":"Mahler","year":"2014","journal-title":"Addict. Biol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.108554_bib0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00952990600920425","article-title":"Modafinil and cocaine interactions","volume":"32","author":"Malcolm","year":"2006","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"5","key":"10.1016\/j.drugalcdep.2021.108554_bib0145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.drugalcdep.2021.108554_bib0150","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.108554_bib0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1176\/appi.ajp.2009.09050613","article-title":"Normalizing effects of modafinil on sleep in chronic cocaine users","volume":"167","author":"Morgan","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2015.12.004","article-title":"Modafinil and sleep architecture in an inpatient\u2013outpatient treatment study of cocaine dependence","volume":"160","author":"Morgan","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-020-00815-4","article-title":"Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder","author":"Negus","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.108554_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00008877-200203000-00002","article-title":"Acute behavioral and physiological effects of modafinil in drug abusers","volume":"13","author":"Rush","year":"2002","journal-title":"Behav. Pharmacol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.108554_bib0175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/1874473711205040006","article-title":"Efficacy of contingency management for cocaine dependence treatment: a review of the evidence","volume":"5","author":"Schierenberg","year":"2012","journal-title":"Curr. Drug Abuse Rev."},{"issue":"77","key":"10.1016\/j.drugalcdep.2021.108554_bib0180","article-title":"Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation","volume":"3","author":"Schmitz","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2013.12.015","article-title":"A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone","volume":"136","author":"Schmitz","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.drugalcdep.2021.108554_bib0190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/M17-1812","article-title":"Trends in U.S. Drug overdose deaths in non-hispanic black, hispanic, and non-hispanic white persons, 2000\u20132015","volume":"168","author":"Shiels","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0195","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53)","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2014.05.008","article-title":"Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study","volume":"141","author":"Verrico","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.drugalcdep.2021.108554_bib0205","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"issue":"2-3","key":"10.1016\/j.drugalcdep.2021.108554_bib0210","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2009.09.002","article-title":"Modafinil does not serve as a reinforcer in cocaine abusers","volume":"106","author":"Vosburg","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2021.108554_bib0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fneur.2013.00139","article-title":"Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions","volume":"4","author":"Wisor","year":"2013","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.drugalcdep.2021.108554_bib0220","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/npp.2017.41","article-title":"The novel modafinil analog, JJC8-016, as a potential cocaine abuse pharmacotherapeutic","volume":"42","author":"Zhang","year":"2017","journal-title":"Neuropsychopharmacology"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871621000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871621000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:10:13Z","timestamp":1793787013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871621000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":44,"alternative-id":["S0376871621000491"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108554","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modafinil reduces smoked cocaine self-administration in humans: effects vary as a function of cocaine \u2018priming\u2019 and cost","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108554"}}